United Therapeutics
Price & Volume
Stats
See more52W Range | $266.98-$549.50 |
Market Cap | $23.3B |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $3.1B |
Revenue Growth (YoY) | 7.4% |
Gross Profit (12 Mos) | $2.7B |
Diluted EPS | $27.85 |
News
See moreYahoo Finance • 7 days ago
Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show Resilience
Yahoo Finance • 11 days ago
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment
Yahoo Finance • 18 days ago
Winners And Losers Of Q4: Biogen (NASDAQ:BIIB) Vs The Rest Of The Therapeutics Stocks
Yahoo Finance • 23 days ago
United Therapeutics Seen as Top Pick on Multiple Near-Term Catalysts, UBS Says
About
CEO | Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D. |
CFO | Mr. James C. Edgemond |
Address | 1000 Spring Street, Silver Spring, MD, United States, 20910 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,400 |
